Scarlet John

@scarletjohld

Interested in peptide research, emerging science, wellness, and the latest developments in peptide-related research and biotechnology.

Joined Sep 2026 Arizona City, United States peptideatlasx.com/

1 Writeups

Follow

Activities Writeups Short Posts Blogs Followers Following

Popular WriteUps

View all →

Semaglutide vs. Tirzepatide vs. Retatrutide: What the Trial Data …

Three GLP-1-class peptides, three different receptor targets, and three very different regulatory outcomes — a source-backed comparison of what each drug's actual clinical trial data shows, and where each one stands today.

0 0 0 0

Recent Activity

Scarlet John posted a new writeup in Work Sep 8, 2026

Work Semaglutide vs. Tirzepatide vs. Retatrutide: What the Trial Data Actually Shows

Three GLP-1-class peptides, three different receptor targets, and three very different regulatory outcomes — a source-backed comparison of what each drug's actual clinical trial data shows, and where each one stands today.

Scarlet John · 4 min read